Insider Selling: Envista (NYSE:NVST) SVP Sells 8,000 Shares

Envista Holdings Corporation (NYSE:NVST) SVP Mischa Reis sold 8,000 shares of the stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $27.50, for a total transaction of $220,000.00. Following the sale, the senior vice president owned 27,321 shares in the company, valued at approximately $751,327.50. The trade was a 22.65% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Envista Stock Up 0.5%

Shares of NVST traded up $0.14 on Monday, hitting $27.34. 1,793,803 shares of the stock traded hands, compared to its average volume of 2,951,562. Envista Holdings Corporation has a one year low of $18.77 and a one year high of $30.42. The company has a market capitalization of $4.39 billion, a PE ratio of 47.15, a P/E/G ratio of 1.30 and a beta of 0.86. The business has a 50 day simple moving average of $26.90 and a 200 day simple moving average of $26.30. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.07 and a current ratio of 2.43.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.07. Envista had a return on equity of 7.88% and a net margin of 3.33%.The business had revenue of $730.50 million for the quarter, compared to analysts’ expectations of $716.11 million. During the same period in the prior year, the firm posted $0.26 EPS. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, equities analysts forecast that Envista Holdings Corporation will post 1.53 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

NVST has been the topic of several recent analyst reports. Wall Street Zen raised Envista from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Barclays decreased their target price on Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a research report on Thursday, June 11th. Weiss Ratings upgraded shares of Envista from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 6th. Piper Sandler reaffirmed a “neutral” rating and set a $28.00 price target (up from $26.00) on shares of Envista in a report on Thursday, August 6th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $29.31.

Hedge Funds Weigh In On Envista

Institutional investors and hedge funds have recently modified their holdings of the company. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in shares of Envista in the 2nd quarter worth $25,000. Caitong International Asset Management Co. Ltd increased its position in Envista by 16,711.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after acquiring an additional 1,504 shares during the last quarter. Allworth Financial LP lifted its holdings in Envista by 75.4% in the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after acquiring an additional 776 shares during the period. Nykredit A S bought a new position in Envista in the second quarter valued at about $52,000. Finally, UMB Bank n.a. boosted its position in Envista by 46.1% in the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after purchasing an additional 636 shares during the last quarter.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.